1. Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature

   • Francesco Motolese
   • Mario Ferrante
   • Fabio Pilato

   Review 21 July 2021 Pages: 4407 - 4414

   

2. Covid-19 and Parkinson’s disease: an overview

   • S. M. Cartella
   • C. Terranova
   • P. Girlanda

   Review 27 July 2021 Pages: 4415 - 4421

3. Neurological and cognitive sequelae of Covid-19: a four month follow-up

   • Flavia Mattioli
   • Chiara Stampatori
   • Giuseppe De Palma

   Original Communication 01 May 2021 Pages: 4422 - 4428

4. The impact of Coronavirus disease 2019 (COVID‐19) pandemic on migraine disorder

   • Faraidoon Haghdoost
   • Cheryl Carcel
   • Candice Delcourt

   Original Communication 05 May 2021 Pages: 4429 - 4435

   

5. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients

   • Rebecca De Lorenzo
   • Nicola I. Loré
   • Roberto Furlan

   Original Communication 10 May 2021 Pages: 4436 - 4442

   

6. Intraluminal carotid thrombosis and acute ischemic stroke associated with COVID-19

   • Diaa Hamouda
   • Dinesh V. Jillella
   • Raul G. Nogueira

   Short Commentary 29 April 2021 Pages: 4443 - 4447

   

7. COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2

   • Shitiz Sriwastava
   • Medha Tandon
   • Robert P. Lisak

   Short Commentary 19 May 2021 Pages: 4448 - 4478

   

8. COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica

   • Ana Maria Cabal-Herrera
   • Farrah J. Mateen

   Letter to the Editors 27 April 2021 Pages: 4479 - 4482

   

9. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis

   • Tilmann Graf
   • Thomas Thiele
   • Isabell Greeve

   Letter to the Editors Open access 22 May 2021 Pages: 4483 - 4485

   

10. Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung

    • Gaetano Bulfamante
    • Tommaso Bocci
    • Alberto Priori

    Letter to the Editors Open access 18 May 2021 Pages: 4486 - 4491

    

11. Pediatric LGI1 and CASPR2 autoimmunity associated with COVID 19: Morvan syndrome

    • Mehmet Akif Kilic
    • Zeynep Nagihan Yoruk Yildirim
    • Meliha Mine Caliskan

    Letter to the Editors 18 May 2021 Pages: 4492 - 4494

12. Neurologic complications of Down syndrome: a systematic review

    • Jonathan D. Santoro
    • Dania Pagarkar
    • Michael S. Rafii

    Review 12 September 2020 Pages: 4495 - 4509

    

13. A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis

    • Emily Beswick
    • Emily Park
    • Suvankar Pal

    Review Open access 10 September 2020 Pages: 4510 - 4521

    

14. Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder

    • Trygve Holmøy
    • Rune Alexander Høglund
    • Øivind Torkildsen

    Review Open access 03 October 2020 Pages: 4522 - 4536

    

15. Efficacy and safety of long-term immunotherapy in adult patients with MOG antibody disease: a systematic analysis

    • Qianshuo Lu
    • Jingjing Luo
    • Feng Gao

    Review 30 September 2020 Pages: 4537 - 4548

    

16. Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis

    • Sasitorn Siritho
    • Tanawin Nopsopon
    • Krit Pongpirul

    Review 10 October 2020 Pages: 4549 - 4562

    

17. Cognitive evaluation in cerebral small vessel disease: towards an evidence-based identification of the reference standards. Part 1. A systematic review and qualitative data synthesis

    • Emilia Salvadori
    • Michela Brambilla
    • Leonardo Pantoni

    Review 13 October 2020 Pages: 4563 - 4572

    

18. Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review

    • Itay Lotan
    • Mark A. Hellmann
    • Israel Steiner

    Review 16 October 2020 Pages: 4573 - 4586

    

19. Contributions of T cells in multiple sclerosis: what do we currently know?

    • Borros Arneth

    Review 20 October 2020 Pages: 4587 - 4593

    

20. A direct aspiration first-pass technique (ADAPT) versus stent retriever for acute ischemic stroke (AIS): a systematic review and meta-analysis

    • Yichi Zhang
    • Yue Zhang
    • Wenqiang Li

    Review 29 October 2020 Pages: 4594 - 4606

    

21. The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?

    • Rangariroyashe H. Chipika
    • We Fong Siah
    • Peter Bede

    Review 31 October 2020 Pages: 4607 - 4629

    

22. Spinocerebellar ataxia type 23 (SCA23): a review

    • Fan Wu
    • Xu Wang
    • Jing Bai

    Review 11 November 2020 Pages: 4630 - 4645

    

23. Central retina changes in Parkinson’s disease: a systematic review and meta-analysis

    • Lele Huang
    • Dan Zhang
    • Ruijun Zhang

    Review 10 November 2020 Pages: 4646 - 4654

    

24. Memory enhancement by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial

    • Nele Schmidt
    • Inken Tödt
    • Karsten Witt

    Original Communication Open access 27 April 2021 Pages: 4655 - 4666

    

25. Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters

    • Benjamin Stolte
    • Michael Nonnemacher
    • Tim Hagenacker

    Original Communication Open access 25 April 2021 Pages: 4667 - 4679

26. A case series of intracranial dural arteriovenous fistulae mimicking cervical myelitis: a diagnosis not to be missed

    • Daniel Whittam
    • Saif Huda
    • Anu Jacob

    Original Communication Open access 26 April 2021 Pages: 4680 - 4686

    

27. Infratentorial pathology in frontotemporal dementia: cerebellar grey and white matter alterations in FTD phenotypes

    • Mary Clare McKenna
    • Rangariroyashe H. Chipika
    • Peter Bede

    Original Communication Open access 13 May 2021 Pages: 4687 - 4697

    

28. A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis

    • Serena Ruggieri
    • Maria Petracca
    • Patrizia Pantano

    Original Communication Open access 03 May 2021 Pages: 4698 - 4706

    

29. Functional connectivity in mild cognitive impairment with Lewy bodies

    • Julia Schumacher
    • John-Paul Taylor
    • Alan J. Thomas

    Original Communication Open access 29 April 2021 Pages: 4707 - 4720

    

30. Iron-sensitive magnetic resonance imaging in Parkinson’s disease: a systematic review and meta-analysis

    • Se Jin Cho
    • Yun Jung Bae
    • Jae Hyoung Kim

    Original Communication 29 April 2021 Pages: 4721 - 4736

    

31. Functional motor phenotypes: to lump or to split?

    • Michele Tinazzi
    • Christian Geroin
    • Roberto Erro

    Original Communication Open access 07 May 2021 Pages: 4737 - 4743

32. ASPECTS-based net water uptake as an imaging biomarker for lesion age in acute ischemic stroke

    • XiaoQing Cheng
    • Hang Wu
    • GuangMing Lu

    Original Communication 02 May 2021 Pages: 4744 - 4751

    

33. Progressive apraxia of speech: delays to diagnosis and rates of alternative diagnoses

    • Johnny Dang
    • Jonathan Graff-Radford
    • Hugo Botha

    Original Communication 04 May 2021 Pages: 4752 - 4758

34. Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PD

    • J. Naisby
    • R. A. Lawson
    • A. J. Yarnall

    Original Communication Open access 15 May 2021 Pages: 4759 - 4767

    

35. Association of intracranial vessel wall enhancement and cerebral hemorrhage in moyamoya disease: a high-resolution magnetic resonance imaging study

    • Mingming Lu
    • Hongtao Zhang
    • Jianming Cai

    Original Communication 06 May 2021 Pages: 4768 - 4777

    

36. The socioeconomic burden of facioscapulohumeral muscular dystrophy

    • Anna M. Blokhuis
    • Johanna C. W. Deenen
    • Jan T. Groothuis

    Original Communication Open access 27 May 2021 Pages: 4778 - 4788

    

37. HIV-Dementia Scale as a screening tool for the detection of subcortical cognitive deficits: validation of the Italian version

    • C. Montanucci
    • E. Chipi
    • L. Parnetti

    Original Communication Open access 15 May 2021 Pages: 4789 - 4795

    

38. Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis

    • Franziska E. Hildesheim
    • Ralph H. B. Benedict
    • Niels Bergsland

    Original Communication 16 May 2021 Pages: 4796 - 4808

    

39. Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study

    • Tobias Zrzavy
    • Anna Pfitzner
    • Uwe Klaus Zettl

    Original Communication Open access 18 May 2021 Pages: 4809 - 4815

    

40. Occurrence of status epilepticus in persons with epilepsy is determined by sex, epilepsy classification, and etiology: a single center cohort study

    • Lisa Langenbruch
    • Christine Strippel
    • Stjepana Kovac

    Original Communication Open access 21 May 2021 Pages: 4816 - 4823

    

41. MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation

    • Nicole König
    • Henning R. Stetefeld
    • for The German Myasthenic Crisis Study Group

    Original Communication Open access 10 May 2021 Pages: 4824 - 4833

    

42. Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis

    • Silvia Tommasin
    • Sirio Cocozza
    • Patrizia Pantano

    Original Communication Open access 10 May 2021 Pages: 4834 - 4845

    

43. Expanding the clinical and neuroimaging features of post-varicella arteriopathy of childhood

    • Marta Bertamino
    • Sara Signa
    • in behalf of Gaslini Stroke Study Group

    Original Communication 27 May 2021 Pages: 4846 - 4865

    

44. Mutations in MT-ATP6 are a frequent cause of adult-onset spinocerebellar ataxia

    • Dagmar Nolte
    • Jun-Suk Kang
    • Ulrich Müller

    Original Communication Open access 26 May 2021 Pages: 4866 - 4873

    

45. Comparison of the retinal vascular network and structure in patients with optic neuritis associated with myelin oligodendrocyte glycoprotein or aquaporin-4 antibodies: an optical coherence tomography angiography study

    • Jian Yu
    • Yongheng Huang
    • Min Wang

    Original Communication 04 June 2021 Pages: 4874 - 4881

    

46. Shared Individual Formulation Therapy (SIFT): an open-label trial of a new therapy accommodating patient heterogeneity in functional neurological disorder

    • M. Gutkin
    • R. J. Brown
    • R. A. Kanaan

    Original Communication 19 September 2021 Pages: 4882 - 4889

    

47. Correction to: Shared Individual Formulation Therapy (SIFT): an open-label trial of a new therapy accommodating patient heterogeneity in functional neurological disorder

    • M. Gutkin
    • R. J. Brown
    • R. A. Kanaan

    Correction 05 October 2021 Pages: 4890 - 4890

    

48. Primary ventriculitis presenting with isolated vestibular syndrome

    • Keun-Tae Kim
    • Seol-Hee Baek
    • Ji-Soo Kim

    Letter to the Editors 24 June 2021 Pages: 4891 - 4893

    

49. Vestibular function testing in patients with RFC1 mutations

    • Gábor M. Halmágyi
    • David J. Szmulewicz

    Letter to the Editors 13 July 2021 Pages: 4894 - 4896

    

50. Elderly onset neuromyelitis optica spectrum disorder: a case report

    • S. Leguy
    • E. Le Page
    • S. Drapier

    Letter to the Editors 16 August 2021 Pages: 4897 - 4898